75. PROGRAMMED DEATH RECEPTOR LIGAND ONE EXPRESSION MAY INDEPENDENTLY PREDICT SURVIVAL IN NON-SMALL CELL LUNG CARCINOMA BRAIN METASTASES PATIENTS RECEIVING IMMUNOTHERAPY

BACKGROUND: Programmed death receptor ligand one (PD-L1) expression is known to predict response to PD-1/PD-L1 inhibitors in non-small cell lung cancer (NSCLC). However, the predictive role of this biomarker in brain metastases (BMs) is unknown. The aim of this study was to assess whether PD-L1 expr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neurooncol Adv
Huvudupphovsmän: Hulsbergen, Alexander, Mammi, Marco, Nagtegaal, Steven, Malk, Asad, Kavouridis, Vasileios, Smith, Timothy, Iorgulescu, Bryan, Mekary, Rania, Verhoeff, Joost, Broekman, Marike, Phillips, John
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2020
Ämnen:
Supplement Abstracts
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7401370/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa073.062
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk